Boryung wins patent dispute against Sanofi Aventis

Published: 2010-05-20 06:58:00

Updated: 2010-05-20 06:58:00

Boryung Pharm has been making strides in expanding its marketing scope in promising medications by successfully winning six patent disputes.

Boryung has won a patent infringement lawsuit of Taxotere (docetaxel) it filed against Sanofi Aventis, the latest development in an ongoing legal tussule...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK